A detailed history of Columbia Trust CO 01012016 transactions in Pfizer Inc stock. As of the latest transaction made, Columbia Trust CO 01012016 holds 7,074 shares of PFE stock, worth $185,621. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,074
Previous 7,949 11.01%
Holding current value
$185,621
Previous $263,000 22.81%
% of portfolio
0.09%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 17, 2024

SELL
$26.13 - $33.94 $22,863 - $29,697
-875 Reduced 11.01%
7,074 $203,000
Q3 2023

Oct 16, 2023

BUY
$32.09 - $37.51 $5,006 - $5,851
156 Added 2.0%
7,949 $263,000
Q2 2023

Jul 18, 2023

SELL
$36.12 - $41.79 $11,124 - $12,871
-308 Reduced 3.8%
7,793 $285,000
Q1 2023

Apr 11, 2023

SELL
$39.39 - $51.28 $69,365 - $90,304
-1,761 Reduced 17.86%
8,101 $330,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $35,821 - $46,761
-858 Reduced 8.0%
9,862 $505,000
Q3 2022

Oct 11, 2022

BUY
$43.76 - $53.42 $38,290 - $46,742
875 Added 8.89%
10,720 $469,000
Q1 2022

Apr 15, 2022

BUY
$45.75 - $56.69 $83,493 - $103,459
1,825 Added 22.76%
9,845 $523,000
Q3 2021

Oct 14, 2021

BUY
$39.25 - $50.42 $14,326 - $18,403
365 Added 4.77%
8,020 $345,000
Q2 2021

Jul 13, 2021

SELL
$35.91 - $40.68 $42,984 - $48,693
-1,197 Reduced 13.52%
7,655 $300,000
Q1 2021

Apr 16, 2021

SELL
$33.49 - $37.77 $58,306 - $65,757
-1,741 Reduced 16.44%
8,852 $320,000
Q4 2020

Jan 21, 2021

BUY
$33.47 - $42.56 $38,858 - $49,412
1,161 Added 12.31%
10,593 $389,000
Q2 2020

Jul 21, 2020

SELL
$30.12 - $36.54 $24,849 - $30,145
-825 Reduced 8.04%
9,432 $308,000
Q1 2020

May 06, 2020

BUY
$27.03 - $38.62 $16,272 - $23,249
602 Added 6.24%
10,257 $334,000
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $317,842 - $360,710
9,655 New
9,655 $377,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Columbia Trust CO 01012016 Portfolio

Follow Columbia Trust CO 01012016 and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Trust CO 01012016, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Trust CO 01012016 with notifications on news.